Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-29T14:20:42.689Z Has data issue: false hasContentIssue false

World psychiatric literature

Published online by Cambridge University Press:  02 January 2018

G. A. Fava
Affiliation:
Department of Psychology, University of Bologna, Viale Berti Pichat 5, 40127 Bologna, Italy
F. Ottolini
Affiliation:
Department of Psychology, University of Bologna, Viale Berti Pichat 5, 40127 Bologna, Italy
E. Tossani
Affiliation:
Department of Psychology, University of Bologna, Viale Berti Pichat 5, 40127 Bologna, Italy
Rights & Permissions [Opens in a new window]

Abstract

Type
Columns
Copyright
Copyright © 2001 The Royal College of Psychiatrists 

Parker (Reference Fava, Ottolini and Sonino2001) expertly reviews the evidence for efficacy and effectiveness of different classes of antidepressants. In particular, he addresses the issue of whether selective serotonin reuptake inhibitors (SSRIs) are less efficacious in melancholia; reviews effectiveness studies; examines why there is a discordance between efficacy studies and clinical observation; and reviews the implications of differential effectiveness.

An additional important area that should be considered is that of gender differences in treatment response to antidepressants. Recent evidence has arisen to suggest that women may have a better response to SSRIs and men a better response to tricyclic antidepressants (Reference Fava and MontanariKornstein et al, 2000). As depression is approximately twice as common in women than in men, gender differences of this nature are important and should be considered when reviewing this area. The reasons for this difference may be related to the effects of female sex hormones on serotonergic neurotransmission and in particular on the function of the 5-HT1A receptor (Reference Patel and SumathipalaYoung et al, 1993). The evidence for gender differences in treatment response to antidepressant is not definitive (Reference Fava and OttoliniKornstein et al, 2001; Reference Left and ChengQuitkin et al, 2001) and further studies are needed to fully establish the validity of this notion. However, there are potentially important implications, and in the future clinical management strategies may take account of gender differences in treatment response.

Footnotes

EDITED BY MATTHEW HOTOPF

Declaration of interest

I have received speakers' fees from pharmaceutical companies that manufacture SSRIs.

References

Fava, G. A. & Montanari, A. (1998) National trends in behavioral sciences (1981–1996). Psychotherapy and Psychosomatics, 67, 281301.10.1159/000012294Google Scholar
Fava, G. A. & Ottolini, F. (2000) Impact factors versus actual citations. Psychotherapy and Psychosomatics, 69, 285286.10.1159/000012409Google Scholar
Fava, G. A. Ottolini, F., & Sonino, N. (2001) Which are the leading countries in clinical medicine research? A citation analysis (1981–1998). Psychotherapy and Psychosomatics, 70, 283287.10.1159/000056268Google Scholar
Left, J. Cheng, A. T. A. (2001) Invited commentaries on: International representation in psychiatric literature. Survey of six leading journals. British Journal of Psychiatry, 178, 410411.Google Scholar
Patel, V. & Sumathipala, A. (2001) International representation in psychiatric literature. Survey of six leading journals. British Journal of Psychiatry, 178, 406409.10.1192/bjp.178.5.406Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.